Affiliation:
1. Anti-Infectives Research Departments,1
2. Department of Molecular Cell Biology & Genetics, University Maastricht, Maastricht, The Netherlands2
3. Immunology Department,3
4. Analytical Department,4 and
5. Biotechnology Department,5 Janssen Research Foundation, Beerse, Belgium;
6. Institut de Microbiologie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland6; and
Abstract
ABSTRACT
The effects of itraconazole on ergosterol biosynthesis were investigated in a series of 16 matched clinical
Candida albicans
isolates which had been previously analyzed for mechanisms of resistance to azoles (D. Sanglard, K. Kuchler, F. Ischer, J. L. Pagani, M. Monod, and J. Bille, Antimicrob. Agents Chemother., 39:2378–2386, 1995). Under control conditions, all isolates contained ergosterol as the predominant sterol, except two strains (C48 and C56). In isolates C48 and C56, both less susceptible to azoles than their parent, C43, substantial concentrations (20 to 30%) of 14α-methyl-ergosta-8,24(28)-diene-3β,6α-diol (3,6-diol) were found. Itraconazole treatment of C43 resulted in a dose-dependent inhibition of ergosterol biosynthesis (50% inhibitory concentration, 2 nM) and accumulation of 3,6-diol (up to 60% of the total sterols) together with eburicol, lanosterol, obtusifoliol, 14α-methyl-ergosta-5,7,22,24(28)-tetraene-3βol, and 14α-methyl-fecosterol. In strains C48 and C56, no further increase of 3,6-diol was observed after exposure to itraconazole. Ergosterol synthesis was less sensitive to itraconazole inhibition, as was expected for these azole-resistant isolates which overexpress ATP-binding cassette transporter genes
CDR1
and
CDR2
. In addition to 3,6-diol, substantial amounts of obtusifolione were found after exposure to itraconazole. This toxic 3-ketosteroid was demonstrated previously to accumulate after itraconazole treatment in
Cryptococcus neoformans
and
Histoplasma capsulatum
but has not been reported in
Candida
isolates. Accumulation of obtusifolione correlated with nearly complete growth inhibition in these azole-resistant strains compared to that found in the susceptible parent strain, although the onset of growth inhibition only occurred at higher concentrations of itraconazole.
ERG25
and
ERG26
are the only genes assigned to the 4-demethylation process, of which the 3-ketoreductase is part. To verify whether mutations in these
ERG25
genes contributed to obtusifolione accumulation, their nucleotide sequences were determined in all three related isolates. No mutations in
ERG25
alleles of isolates C48 and C56 were found, suggesting that this gene is not involved in obtusifolione accumulation. The molecular basis for the accumulation of this sterol in these two strains remains to be established.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology